NCT00429910
- Conditions
- Blast Crisis, Bone Marrow Diseases, Carcinogenesis, +16 more
- Locations
-
- Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute Boston, Massachusetts, United States
Clinical trial condition
Explore clinical trials studying Leukemia, Myelogenous, Chronic, BCR-ABL Positive. Study availability and eligibility vary by location and protocol.
NCT00429910
NCT00104975
NCT02977312
NCT01660906
NCT00123474
NCT00006348
NCT01218477
NCT01395628
Not specified
NCT01056614
NCT01204164